BioLine RX Ltd (NASDAQ:BLRX)

2.77
Delayed Data
As of Oct 11
 +0.03 / +1.09%
Today’s Change
2.32
Today|||52-Week Range
22.05
-57.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization440.8K483.5K484.4K449.5K
 
 
 
 
 
 
Operating ExpensesGross Income-440.8K-483.5K-484.4K-449.5K
 
 
 
 
 
General Expenses15.7M16.1M24.9M25.1M
 
 
 
 
 
Research And Development11.1M10.8M19.2M19.3M
 
 
 
 
 
Total Operating Expenses16.2M16.6M25.4M25.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.2M-16.6M-25.4M-25.5M
 
 
 
 
 
Extraordinary Credit1.4M207.7K347.4K1.7M
 
 
 
 
 
Extraordinary Charge0.00---127.9K--
 
 
Interest Expense On Debt15.0K14.0K21.1K471.5K
 
 
 
 
 
Other Expenses-91.0K-1.0K-133.9K651.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.4M-15.9M-24.5M-22.9M
 
 
 
 
 
Net Income-14.4M-15.9M-24.5M-22.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.4M3.7M6.0M7.2M
 
 
 
 
 
Shares To Calculate EPS Diluted3.4M3.7M6.0M7.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.20-$4.21-$4.08-$3.16
 
 
 
 
 
EPS Diluted-$4.20-$4.21-$4.08-$3.16